Q4 Editor’s Picks: Clinical Trial Regulation

 
• By Denise Peterson

Coverage of clinical trial policy included commentary on rapid growth of the PD-1 pipeline by both US and China regulators; case studies and discussion of trial strategies including RWE, pediatric studies and decentralized trials; and US FDA commissioner-nominee Robert Califf’s R&D expertise.  

Pink Sheet Q4 Editor's Picks
From real-world evidence to the cancer pipeline, Q4 featured lively and diverse clinical trial coverage. • Source: Alamy

More from Clinical Trials

More from R&D